Author:
Togawa Tatsuya,Furukubo Taku,Satoh Minori,Matsunaga Chiharu,Izumi Satoshi,Yamakawa Tomoyuki,Sugioka Nobuyuki,Takada Kanji
Publisher
Japanese Society of Pharmaceutical Health Care and Sciences
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference19 articles.
1. 1)M.K.Almond,S.Fan,S.Dhillon,A.M.Pollock,M.J.Raftery,Avoiding acyclovir neurotoxicity in patients with chronic renal failure undergoing haemodialysis,Nephron ,69,428-432 (1995).
2. 2)R.J.de Knegt,H.van der Pijl,L.A.van Es,Acyclovirassociated encephalopathy,lack of relationship between acyclovir levels and symptoms,Nephrol.Dial.Transplant .,10,1775-1777 (1995).
3. High serum concentrations of the acyclovir main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related neuropsychiatric side effects: an observational study
4. 4)A.Hellden,J.Lycke,J.O.Svensson,I.Odar-Cederlof,L.Stahle,The aciclovir metabolite CMMG is detectable in the CSF of subjects with neuropsychiatric symptoms during aciclovir and valaciclovir treatment,Journal of Antimicrobial Chemotherapy ,57,945-949 (2006).
5. 5)M.R.Blum,S.H.Liao,P.de Miranda,Overview of acyclovir pharmacokinetic disposition in adults and children,The American Journal of Medicine (Acyclovir Symposium),73,186-192 (1982).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献